Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
New here and obviously missing something . Can anyone help with a presentation that covers it all . Starting to nibble on a pull back . I don’t normally say this but if this was state side listed … wow .. BP will be licking their lips
I wonder if anyone finds this interesting. We might see a similar deal i guess.I wonder if someone with more experience in science would have an opinion and discuss any similarities/. Much appreciated if anyone could spare some time.
https://medcitynews.com/2023/09/seagen-nurix-cancer-antibody-drug-conjugate-protein-degrader/
Have you read this, absolutely pathetic.The whole sector should be nationalised and have ONDO in every house.https://www.theguardian.com/business/2023/jul/25/thames-water-smart-meters-green-scheme?utm_term=64bf73531380548ee4e4ccf6b9ec3e41&utm_campaign=BusinessToday&utm_source=esp&utm_medium=Email&CMP=bustoday_email
Im not sure water companies will invest. its insurance. Water companies are delighted with leaks as they earn more. I know I sound childish but I am absolutely appalled by their recent behaviour. In fact their behaviour over the last 20 years. The opportunities here are wonderful, as it is so needed for the environment. As I stated last week.I lived in the middle east, and their water loss/cost is multiplies of Europe with water desalination plants.Perhaps the water companies will and should be legally required to have monitors on their pipes .They are about to get absolutely hauled over the coals by the government as it's now going to impact the next election in my opinion.Sky is the limit .I agree the only real threat is maybe their manufacturing ... but who wouldn't exists.
Love this story, Sorry if im being lazy. What manufacturing opportunities have the company got?I assume they are using a third party? Any thoughts on them not being able to supply efficiently/It's the only thing that could possibly go wrong.I personally had a water leak last year. Suddenly got a massive bill and was shocked to see how little the meter was looked at by the water company, never mind if there was water damage. Countries like Saudi Arabia where All water comes hundreds of kilometres away and all desalination plants. It costs millions and their loss through leaks is mind-boggling. The potential is very exciting. just google Lake meade in LA and it will show you where global freshwater supplies are going.The world's most precious commodity is about to get much more expensive in my opinion
Is there any info on how and where they manufacture their kit? is this on the website thankyou for anyone help
Still down a lot but very relieved as I really had to ask myself what was going on with this asset with regard to its NAV.Funny old world how the management could just get no investors in here at all. Share price was completely ignored despite some fund involvement . Onwards and hopefully upwards for me, no idea where to put my money now. Certainly hard to replace this dividend. I3 energy have it but looks unloved as well and who knows where the oil/gas prices are going .Good luck everyone and well hung in there
Gas prices are on their knees. This looks like a poisonous raise. Anything with warrants is just too tempting for the new holders to sell into strength and run the warrants for free. I see it in the States all the time. It's a shame. Big position here and it's almost all gone. These technologies should be receiving far more support but maybe something is wrong. Given it 2 years. Looks like a death spiral. I hope I am wrong and wish all holders success. I should have sold it yesterday. Appreciate everyone's input here as ever .
Any thoughts on why these results are not in the press? I think it's a bit early and might be better served to have a patient who has survived despite being given a very poor prognosis to add a bit more interest. Possibly a bit too technical still but with some of the rubbish you see in the press regarding new treatments (many years away and total rubbish) I am kind of surprised we haven't had any journalist sniffing about. Especially with the UK trying to establish a better reputation for scientific growth.
I hope I am not being overly harsh, but reading through how much this has cost the company is an absolute sham. Surely someone should resign?
Watched their presentation from the end of last year, where they said they didn't need to raise. Now they have taken on this ridiculous loan which has cost a fortune and dropped the share price to almost an all-time low for a massive dilution. Very disappointed siemens haven't gotten involved in the raises as that was what got ITM Power going all those years ago and would of course shown faith in what they are producing. Very long here and love the space but this has been an absolute balls up and is going to take many months to get the share back to where we think it should be.
Someone should resign .
https://finance.yahoo.com/news/merck-provides-phase-3-trials-114500104.html
Merck, getting desperate. keytruda is out of patent soon and the world's biggest-selling cancer drug struggling to find a new path. Keytruda hasn't saved anywhere near as many lives as chemotherapy. Imagine if you could up the dose?
Don't assume big funds do not have scientists on their books. Here below is an example I was told the other day when I criticised an investment note on a company I own in the States.
Dr. Pantginis is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the healthcare sector. Dr. Pantginis conducted more than seventeen years of healthcare equity research.
Prior to joining H.C. Wainwright, Dr. Pantginis worked as a Senior Research Analyst and Head of Biotechnology Research at ROTH Capital Partners. Dr. Pantginis also held senior positions at Merriman, Canaccord Adams, Commerce Capital Markets, JBHanauer and Ladenburg. Prior to his equity research career, Dr. Pantginis worked at Regeneron Pharmaceuticals, where he founded the Retroviral Core Facility.
yes, i think this is the issue here. My understanding is all patients have already had dox in its pure form so differentiating the patient's state of health can be tricky. Does this mean there needs to be a placebo group? Or will this come later? I hope not as this is very unfair in the patient group and certainly placebo groups on a treatment that has been used for 50 years would be unnecessary. Trails take time. You have to have a realistic time scale here, I know that's a cliche but...
Acata could announce a BP to invest in AVA3996 any day. This would take care of any short-term worries about the share price BUT might knock hundreds of millions off an eventual sale price for the company. Tough decisions s and I am sure one that is discussed at board level.
https://finance.yahoo.com/m/bd5ee7f6-1de2-3841-b667-fbaf37b535a6/pfizer-in-talks-to-buy-seagen.html
Dont be sad, it takes time. there are plenty of small Bio trading massively under cash on Nasday. Do your research and keep your fingers and toes crossed.
Look at ACHL ( THIS IS NOT A RECOMMENDATION ) 47 MIO MC CASH 180 MIO. PHASE 1 .
Do your research and wait. The market perhaps was expecting a tie-up. They will need more money to take these trails further, which might be a reason too.
I am long and soon its ISA top-up time.
People are nervous and the technology is very very hard to understand for the average Joe.( me included)
As Warren Buffet has said, if you are sure/confident GO BIG.
or
When you combine ignorance and leverage, you get some pretty interesting results.
Read more at https://www.brainyquote.com/authors/warren-buffett-quotes
The team at Avacta still have a lot of work to do, let them do it.
the opportunities here are enormous.
Fact
Most cancers are still checked/cured /improved by chemo and resurrection.
You can look at the value of Car T /Ketruda and their billions of dollars in revenue.
Fact is
They still don't really dent cancer compared to chemotherapy.
That is the reality.
We are improving the single best treatment for cancer by the percentage of Doxorubicin that is being shown in the tumour compared to the amount in plasma.
FACT
Tuck your shares away and enjoy the ride
So avaca concentrates on STS. But these include a wide range of cancers. So dox is only used on some of these cancers I assume? There fore if avacta wants to go after ovarian cancer as an example is that a separate trial using dox?
Sorry, I am confused as I don't understand why people are trying to assess the addressable market as only what dox sales are. Because surely dox without side effects surpass many other chemotherapies? I just can't get my head around whether dox has to be re-trailed for certain cancer types. I guess I haven't read enough about different chemo and why some are more suited to certain types of cancer. Thank you for anyone's time.
https://www.gov.uk/government/consultations/10-year-cancer-plan-call-for-evidence/10-year-cancer-plan-call-for-evidence
Alongside improvements in traditional treatment routes, novel treatments such as cancer immunotherapy (also known as immuno-oncology therapy) have emerged. This development has been fuelled by an increased understanding and characterisation of the immune system’s role in cancer. Immuno-oncology is showing significant promise. It involves the development of innovative and targeted therapies to activate the body’s immune system against tumour cells. The Life Sciences Vision sets out our ambition to grow the UK’s global leadership in this area and begin to explore the potential for cancer vaccines by combining our deep expertise in immuno-oncology with the advanced vaccine capabilities developed through the pandemic. Utilising existing infrastructure and successes, we will support industry to commercialise new cancer treatments.